1. Market Research
  2. > Pharmaceutical Market Trends
  3. > OTC Pharmaceuticals: Scandinavia Industry Guide

OTC Pharmaceuticals: Scandinavia Industry Guide

  • October 2014
  • -
  • MarketLine
  • -
  • 77 pages

Introduction

The Scandinavian OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Scandinavian OTC pharmaceutica
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the Scandinavian OTC pharmaceuticals market
* Leading company profiles reveal details of key OTC pharmaceuticals players' Scandinavian operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavian OTC pharmaceuticals market with forecasts
* Compares data from Denmark, Norway and Sweden, alongside individual chapters on each country

Highlights

The Scandinavian OTC pharmaceuticals market had a total market value of $1,223.8 million in 2013. Norway was the fastest growing country with a CAGR of 3.8% over the 2009-13 period.
Within the OTC pharmaceuticals industry, Sweden is the leading country among the Scandinavian countries, with market revenues of $583.8 million in 2013. This was followed by Norway and Denmark, with $364.3 and $275.6 million, respectively.
Sweden is expected to lead the OTC pharmaceuticals in the Scandinavian countries, with a value of $725.9 million in 2018, followed by Norway and Denmark with expected values of $438.8 and $305.5 million respectively.

Your key questions answered

* What was the size of the Scandinavian OTC pharmaceuticals market by value in 2013?
* What will be the size of the Scandinavian OTC pharmaceuticals market in 2018?
* What factors are affecting the strength of competition in the Scandinavian OTC pharmaceuticals market?
* How has the market performed over the last five years?

Table Of Contents

OTC Pharmaceuticals: Scandinavia Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
SCANDINAVIA OTC PHARMACEUTICALS
Industry Outlook
OTC PHARMACEUTICALS IN DENMARK
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN NORWAY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN SWEDEN
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
COMPANY PROFILES
Leading companies
APPENDIX
Methodology

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.